Crossmark

Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic

Crossref DOI link: https://doi.org/10.1007/s11136-021-02917-y

Published Online: 2021-06-22

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Souliotis, Kyriakos

Giannouchos, Theodoros V. https://orcid.org/0000-0002-1574-6767
Golna, Chistina

Liberopoulos, Evangelos
Funding

Funding for this research was provided by:

Servier Hellas
License Information

Text and Data Mining valid from 2021-06-22

Version of Record valid from 2021-06-22
More Information

Article History

Accepted: 14 June 2021

First Online: 22 June 2021

Declarations

:

: The authors declares that they have no conflict of interest.

: All procedures were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by an independent research ethics committee of the Health Policy Institute, Athens, Greece.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below